For businesses engaged in pharmaceutical research and development or API manufacturing, understanding the factors influencing the price and availability of key intermediates is essential for strategic procurement. 2,4-Dichloro-5-fluoropyrimidine (CAS 2927-71-1) is one such compound, critical for the synthesis of advanced therapeutics, most notably Abemaciclib. When considering a bulk purchase, several elements come into play.

The price of 2,4-Dichloro-5-fluoropyrimidine is influenced by several factors, including the cost of raw materials, the complexity of the synthesis process, energy costs, and economies of scale achieved by the manufacturer. As a specialized fluorinated pyrimidine derivative, its production requires specific expertise and controlled conditions, which can contribute to its overall cost. Manufacturers in China often offer competitive pricing due to efficient production infrastructure and supply chain management.

Availability is another crucial consideration. Consistent supply hinges on the manufacturer's production capacity, raw material sourcing stability, and global demand. For companies seeking to buy CAS 2927-71-1 in larger quantities, establishing a long-term relationship with a reliable supplier is key. This ensures not only consistent availability but also helps in securing favorable pricing through bulk purchase agreements. Our commitment as a China-based manufacturer is to maintain robust production capabilities and a stable supply chain for this vital pharmaceutical intermediate.

We understand that pharmaceutical companies require transparency and reliability. Therefore, we aim to provide clear information regarding the price and availability of 2,4-Dichloro-5-fluoropyrimidine, catering to both R&D needs and large-scale manufacturing requirements. Whether you are seeking a small quantity for initial research or a substantial volume for commercial production, partnering with experienced suppliers ensures that you receive high-quality intermediates without compromising on timelines or budget. The strategic acquisition of intermediates like CAS 2927-71-1 is a cornerstone of successful pharmaceutical development.